Patterns of intravenous glucose tolerance and insulin response before and after treatment with streptozotocin (NSC-85998) in patients with cancer.
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000378:metabolism; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D003404:Creatinine / Q000097:blood; D004361:Drug Tolerance; D004573:Electrolytes / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D013006:Growth Hormone / Q000097:blood; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D008111:Liver Function Tests; D009369:Neoplasms / Q000188:drug therapy*; D009603:Nitroso Compounds / Q000627:therapeutic use*; D010758:Phosphorus / Q000097:blood; D013311:Streptozocin / Q000009:adverse effects / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D001786:Blood Glucose; D004573:Electrolytes; D007328:Insulin; D009603:Nitroso Compounds; D010758:Phosphorus; D013311:Streptozocin; D014508:Urea; D013006:Growth Hormone; D003404:Creatinine; D005947:Glucose